Opens door to easy, early identification of individuals at risk for delirium complications
Regenstrief Institute and Indiana University School of Medicine researchers have identified blood-based biomarkers associated with both delirium duration and severity in critically ill patients. This finding opens the door to easy, early identification of individuals at risk for longer delirium duration and higher delirium severity and could potentially lead to new treatments of this brain failure for which drugs have been shown to be largely ineffective.
An estimated 7 million hospitalized Americans suffer from the acute confusion and disorientation, characteristics of delirium, including a majority of patients in medical or surgical intensive care units (ICUs). Individuals who experience delirium in the ICU are more likely to have more hospital-associated complications, longer stays and higher risk of readmission. They are more likely to experience cognitive impairment and also have a greater likelihood of dying for up to a year after their hospital stay than ICU patients who did not experience delirium.
“If you can tell which patients will have higher delirium severity and longer duration and therefore greater probability of death, there are important treatment implications,” said Regenstrief Institute research scientist and IU School of Medicine faculty member Babar Khan, M.D., who led the research and is the president of the American Delirium Society. “Analyzing biomarkers to stratify risk for delirium is a promising approach with the potential to be applied regularly in ICU patients in the near future.”
In a new observational study, Dr. Khan and colleagues report that biomarkers for astrocyte and glial activation as well as for inflammation were associated with increased delirium duration and severity and greater in-hospital mortality.
Biomarkers of the 321 study participants, all of whom experienced delirium in an ICU, were identified from samples obtained via simple blood draws. Delirium severity was determined using a tool developed by a team including Regenstrief, IU School of Medicine and Purdue College of Pharmacy scientists. The CAM-ICU-7, short for Confusion Assessment Method for the Intensive Care Unit 7 — is easy to administer, even to patients on mechanical ventilators. More than half of ICU patients in the U.S. receive mechanical ventilation.
Each day with delirium in the ICU is associated with a 10 percent increased likelihood of death, according to Dr. Khan, so diminishing its duration and ultimately preventing it is critical. Regenstrief, IU School of Medicine and research scientists from other institutions have conclusively shown in several large trials that antipsychotics, such as the widely used haloperidol, are not effective for the management of delirium duration or severity.
Regenstrief and IU School of Medicine researchers are actively exploring other approaches to delirium. Dr. Khan is co-principal investigator of an ongoing study that is the first to test whether listening to music, a non-pharmacological strategy that has been shown to decrease over-sedation, anxiety and stress in critically ill patients — all factors that predispose to ICU delirium – and lowers the likelihood of developing delirium. In a completed study, Regenstrief researchers determined that waking ICU patients and having them breathe on their own decreased acute brain failure.
The new study, “Biomarkers of Delirium Duration and Delirium Severity in the ICU” has been published online ahead of print in the journal Critical Care Medicine.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- How Covid-19 can damage the brainon June 23, 2020 at 1:55 pm
It has been very scary, especially because many of the people we treated were very young – many in their 30s and 40s, even an 18-year-old.” Helms and her colleagues published a small study in the New ...
- After the ICU: A 'Fraternity of People Who Are Struggling'on June 18, 2020 at 6:32 am
Thousands of coronavirus patients have survived the ICU. Now, a prepandemic research movement may help physicians figure out how to help them through what comes next.
- Op-Ed: Seniors are dying because of COVID-19, not of iton June 17, 2020 at 2:53 am
Coronavirus has led to social isolation and lack of caregiver support. That can be fatal for fragile elderly people who don't have the virus.
- COVID-19 Effects: Doctors Report Delirium, Terrifying Hallucinations, More Neurological Problemson June 15, 2020 at 11:14 pm
A new study shows that many patients experienced delirium, disorientation, difficulty concentrating and other neurological symptoms after recovering from severe coronavirus infections.
- Frank Bures: Delirium and COVID patientson June 13, 2020 at 10:00 pm
More information continues to emerge about the medical problems COVID-19 infections can cause as our experience with it grows.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- How Covid-19 can damage the brainon June 23, 2020 at 3:01 am
Some scientists suspect that Covid-19 causes respiratory failure and death not through damage to the lungs, but the brain – and other symptoms include headaches, strokes and seizures.
- Nursing Care, Delirium, and Pain Management for the Hospitalized Older Adulton June 19, 2020 at 5:00 pm
For example, an older person with dementia is at a greatly increased risk for developing delirium. Other factors that may predispose these individuals include illness severity and environment with ...
- Coronavirus | Avoid hydroxychloroquine in COVID-19 patients with severe disease, says Health Ministry protocolon June 13, 2020 at 6:09 am
A 22-page new, national clinical management protocol provides for the management of COVID-19 cases based on the clinical severity of mild, moderate or severe, the Health Ministry said.
- Delirium Resolution in Hospitalized Older Patients With Canceron June 12, 2020 at 5:00 pm
A strength of the study was the daily assessment of delirium using an instrument that measures delirium severity and allows monitoring of changes in delirium over time.
- The role of nicotinic cholinergic neurotransmission in delusional thinkingon June 12, 2020 at 2:14 am
including delirium, schizophrenia spectrum disorders, bipolar disorder, Parkinson, Huntington, and Alzheimer diseases. Beginning with what we know about the emergence of delusions in these ...